Skip to main content
IC
GE HealthCare Technologies Inc. (BIT:1GEHC)
Italy flag Italy · Delayed Price · Currency is EUR
60.34
+0.04 (0.07%)
At close: May 7, 2025

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 TTM FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
 Mar '25 Dec '24 Dec '23 Dec '22 Dec '21
Product
13.15B
Log In
Log In
Log In
Log In
Product Growth
0.81%
Log In
Log In
Log In
Log In
Service
6.65B
Log In
Log In
Log In
Log In
Service Growth
3.07%
Log In
Log In
Log In
Log In
Imaging Revenue (Post-Q2 2024)
-
Log In
Log In
Log In
Log In
Imaging Revenue (Post-Q2 2024) Growth
-
Log In
Log In
Log In
Log In
Advanced Visualization Solutions (AVS)
-
Log In
Log In
Log In
Log In
Advanced Visualization Solutions (AVS) Growth
-
Log In
Log In
Log In
Log In
Patient Care Solutions (PCS)
3.13B
Log In
Log In
Log In
Log In
Patient Care Solutions (PCS) Growth
0.74%
Log In
Log In
Log In
Log In
Pharmaceutical Diagnostics (PDx)
2.54B
Log In
Log In
Log In
Log In
Pharmaceutical Diagnostics (PDx) Growth
8.27%
Log In
Log In
Log In
Log In
Other
50.00M
Log In
Log In
Log In
Log In
Other Growth
-26.47%
Log In
Log In
Log In
Log In
Imaging
-
Log In
Log In
Log In
Log In
Imaging Growth
-
Log In
Log In
Log In
Log In
Ultrasound
-
Log In
Log In
Log In
Log In
Ultrasound Growth
-
Log In
Log In
Log In
Log In

EBIT by Product

Fiscal year is January - December.
Fiscal Year
 TTM FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
 Mar '25 Dec '24 Dec '23 Dec '22 Dec '21
Imaging EBIT (Post-Q2 2024)
-
Log In
Log In
Log In
Log In
Imaging EBIT (Post-Q2 2024) Growth
-
Log In
Log In
Log In
Log In
Advanced Visualization Solutions (AVS) EBIT
-
Log In
Log In
Log In
Log In
Advanced Visualization Solutions (AVS) EBIT Growth
-
Log In
Log In
Log In
Log In
Patient Care Solutions (PCS) Segment EBIT
314.00M
Log In
Log In
Log In
Log In
Patient Care Solutions (PCS) Segment EBIT Growth
-11.55%
Log In
Log In
Log In
Log In
Pharmaceutical Diagnostics (PDx) Segment EBIT
810.00M
Log In
Log In
Log In
Log In
Pharmaceutical Diagnostics (PDx) Segment EBIT Growth
26.56%
Log In
Log In
Log In
Log In
Other Segment EBIT
5.00M
Log In
Log In
Log In
Log In
Other Segment EBIT Growth
-37.50%
Log In
Log In
Log In
Log In
Imaging Segment EBIT
-
Log In
Log In
Log In
Log In
Imaging Segment EBIT Growth
-
Log In
Log In
Log In
Log In
Ultrasound Segment EBIT
-
Log In
Log In
Log In
Log In
Ultrasound Segment EBIT Growth
-
Log In
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 TTM FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
 Mar '25 Dec '24 Dec '23 Dec '22 Dec '21
USCAN
9.13B
Log In
Log In
Log In
Log In
USCAN Growth
6.59%
Log In
Log In
Log In
Log In
EMEA
5.05B
Log In
Log In
Log In
Log In
EMEA Growth
-0.26%
Log In
Log In
Log In
Log In
China
2.36B
Log In
Log In
Log In
Log In
China Growth
-13.06%
Log In
Log In
Log In
Log In
Rest of World
3.27B
Log In
Log In
Log In
Log In
Rest of World Growth
3.45%
Log In
Log In
Log In
Log In

Other

Fiscal year is January - December.
Fiscal Year
 TTM FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
 Mar '25 Dec '24 Dec '23 Dec '22 Dec '21
Products Remaining Performance Obligations (RPO)
4.60B
Log In
Log In
Log In
Log In
Products Remaining Performance Obligations (RPO) Growth
-3.02%
Log In
Log In
Log In
Log In
Services Remaining Performance Obligations (RPO)
10.28B
Log In
Log In
Log In
Log In
Services Remaining Performance Obligations (RPO) Growth
7.42%
Log In
Log In
Log In
Log In
Total Remaining Performance Obligations (RPO)
14.88B
Log In
Log In
Log In
Log In
Total Remaining Performance Obligations (RPO) Growth
3.95%
Log In
Log In
Log In
Log In